Cryoport (CYRX) Misses Q4 EPS by 98c, provides guidance
Get Alerts CYRX Hot Sheet
Join SI Premium – FREE
Cryoport (NASDAQ: CYRX) reported Q4 EPS of ($1.31), $0.98 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $57.26 million versus the consensus estimate of $58.4 million.
GUIDANCE:
Cryoport sees FY2024 revenue of $242-252 million, versus the consensus of $253.2 million.
For earnings history and earnings-related data on Cryoport (CYRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baxter (BAX) Tops Q3 EPS by 6c; raises guidance
- Hippo Holdings (HIPO) Tops Q3 EPS by 75c ; Offers Guidance
- Altria Group (MO) Tops Q3 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share